Listed

Verrica Pharmaceuticals Inc.

VRCANasdaqCIK 1660334HealthcareFiscal year ends Dec 31

Reports and events: 160 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Verrica Pharmaceuticals Inc., Reports and events
FiledFormWhat it isAccession number
2024-05-1308:01 ET10-QQuarterly reportPeriod 2024-03-310000950170-24-058208
2024-05-1307:46 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-24-136715
2024-04-1907:30 ETDEF 14AProxy statementPeriod 2024-06-060001193125-24-101650
2024-02-2908:05 ET10-KAnnual reportPeriod 2023-12-310000950170-24-022659
2024-02-2907:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-24-051876
2024-01-0808:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-24-003926
2023-11-0907:54 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-061543
2023-11-0907:41 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-274069
2023-08-0807:52 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-039375
2023-08-0807:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-205590
2023-07-2716:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-196112
2023-07-2616:21 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-194625
2023-07-2407:31 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-191859
2023-06-0816:15 ET8-K5.07 Shareholder vote results0001193125-23-163516
2023-05-0908:27 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-019169
2023-05-0908:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-138946
2023-04-2108:50 ETDEF 14AProxy statementPeriod 2023-06-080001193125-23-109424
2023-03-0608:01 ET10-KAnnual reportPeriod 2022-12-310000950170-23-006118
2023-03-0607:46 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-060702
2023-02-2108:58 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-043040
2023-02-2106:08 ET8-K2.02 Results of operations; 8.01 Other events0001193125-23-042756
2023-02-0216:16 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-022755
2023-01-2407:58 ET8-K8.01 Other events0001193125-23-013704
2022-11-0716:30 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-022647
2022-11-0716:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-279108
2022-09-1408:09 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-244283
2022-08-1108:05 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-016660
2022-08-1107:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-218004
2022-07-1516:15 ETSC 13DOwnership report, active investor0001104659-22-080215
2022-07-1316:16 ET8-K8.01 Other events0001193125-22-192901
2022-07-0108:30 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-186748
2022-06-1416:31 ET8-K5.07 Shareholder vote results0001193125-22-173863
2022-06-0316:16 ET8-K2.05 Exit or disposal costs0001193125-22-167332
2022-05-2507:30 ET8-K8.01 Other events0001193125-22-159075
2022-05-0907:55 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-008242
2022-05-0907:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-144294
2022-04-2216:06 ETDEF 14AProxy statementPeriod 2022-06-090001193125-22-115092
2022-04-0716:17 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-098900
2022-03-0216:56 ET10-KAnnual reportPeriod 2021-12-310000950170-22-002685
2022-03-0216:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-063013
2021-12-1516:26 ET8-K8.01 Other events0001193125-21-357955
2021-11-2917:07 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-342387
2021-11-1207:56 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-004249
2021-11-1207:41 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-327358
2021-09-2916:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-286746
2021-09-2016:28 ET8-K8.01 Other events0001193125-21-277323
2021-08-1008:04 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-042894
2021-08-1008:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-241222
2021-07-0908:28 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-211337
2021-06-1016:39 ET8-K5.07 Shareholder vote results0001193125-21-187840

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:18 ET. Listed shows no prices and gives no investment advice.